ACE Report Cover
Ultrasound- Versus Landmark-Guided Corticosteroid Injections in Patients With Shoulder Pain
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SHOULDER & ELBOW
Ultrasound- Versus Landmark-Guided Corticosteroid Injections in Patients With Shoulder Pain .

Ultrasound- Versus Landmark-Guided Corticosteroid Injections in Patients With Shoulder Pain: A Meta-Analysis and Systematic Review.

J Clin Ultrasound . 2025 Mar-Apr;53(3):525-534.
Contributing Authors

Y Zhang M Hu J Wei C Su C Guo S Xiang H Xu

Thirteen randomized controlled trials including 656 patients with shoulder pain were included in this systematic review and meta-analysis comparing ultrasound-guided (USG) versus landmark-guided (LMG) corticosteroid injections. Pooled outcomes of interest included visual analogue scale (VAS) scores at 1 and 6 weeks postinjection, changes in VAS scores, and shoulder range of motion (ROM) at 6 weeks postinjection. USG injections demonstrated significantly better VAS scores at 1 week and improved abduction ROM at 6 weeks, while other outcomes showed no significant differences. These findings suggest USG injections may provide superior early pain relief and better mid-term improvement in shoulder abduction compared to LMG injections.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Ultrasound- Versus Landmark-Guided Corticosteroid Injections in Patients With Shoulder Pain. ACE Report. 2025;307(5):36. Available from: https://myorthoevidence.com/AceReport/Show/ultrasound-versus-landmark-guided-corticosteroid-injections-in-patients-with-shoulder-pain

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report